Information:
Fel:
ID
12929
Beskrivning
Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00178256
Länk
https://clinicaltrials.gov/show/NCT00178256
Nyckelord
Versioner (1)
- 2016-01-06 2016-01-06 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
6 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Carcinoma, Non-Small-Cell Lung NCT00178256
Eligibility Carcinoma, Non-Small-Cell Lung NCT00178256
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non-Small-Cell Lung NCT00178256
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
lung cancer
Item
histologically confirmed lung cancer, excluding small cell carcinoma
boolean
C0242379 (UMLS CUI [1])
tumor stage
Item
inoperable stage i (t1-2n0) and ii (t1-2n1, t3n0) disease, or stage iiia (t3n1 andt1-3n2m0) and iiib (txn3m0, t4nxm0) diseases according to the american joint committee of cancer criteria 1998
boolean
C1300072 (UMLS CUI [1])
the primary tumor must be radiographically measurable.
Item
the primary tumor must be radiographically measurable.
boolean
C1302351 (UMLS CUI [1])
age
Item
age > 18.
boolean
C0001779 (UMLS CUI [1])
karnofsky performance status
Item
karnofsky performance status > 70.
boolean
C0206065 (UMLS CUI [1])
fev1 sufficient for patients to tolerate radiation therapy which is at the discretion of the radiation oncologist, usually > 800 ml
Item
fev1 sufficient for patients to tolerate radiation therapy which is at the discretion of the radiation oncologist, usually > 800 ml
boolean
C0748133 (UMLS CUI [1])
labs: wbc > 3000; platelet count > 100,000; serum creatinine < 1.5 mg/dl or creatinine clearance >60 ml/min.
Item
labs: wbc > 3000; platelet count > 100,000; serum creatinine < 1.5 mg/dl or creatinine clearance >60 ml/min.
boolean
C0023508 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0373595 (UMLS CUI [4])
C0005821 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0373595 (UMLS CUI [4])
laboratory values must be obtained < 3 weeks prior to registration.
Item
laboratory values must be obtained < 3 weeks prior to registration.
boolean
C0022885 (UMLS CUI [1])
a signed informed consent.
Item
a signed informed consent.
boolean
C0021430 (UMLS CUI [1])
patients who failed prior chemotherapy are eligible. patients with prior radiotherapy to the chest region are eligible as long as the normal tissue tolerance is not violated by repeat radiotherapy.
Item
patients who failed prior chemotherapy are eligible. patients with prior radiotherapy to the chest region are eligible as long as the normal tissue tolerance is not violated by repeat radiotherapy.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
patients with medical contraindication to chemotherapy or radiotherapy.
Item
patients with medical contraindication to chemotherapy or radiotherapy.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
patients with myocardial infarction within the preceding six months or symptomatic heart disease, including uncontrolled or unstable angina, uncontrolled congestive heart failure, and uncontrolled arrhythmia.
Item
patients with myocardial infarction within the preceding six months or symptomatic heart disease, including uncontrolled or unstable angina, uncontrolled congestive heart failure, and uncontrolled arrhythmia.
boolean
C0018799 (UMLS CUI [1])
pregnancy
Item
women who are pregnant.
boolean
C0032961 (UMLS CUI [1])
patients with small cell carcinoma or mesothelioma
Item
patients with small cell carcinoma or mesothelioma
boolean
C0262584 (UMLS CUI [1])
C0025500 (UMLS CUI [2])
C0025500 (UMLS CUI [2])